期刊文献+

智能阴道镜培训软件研发的必要性及挑战

Necessity and Challenge of Developing Intelligent Colposcopy
原文传递
导出
摘要 我国基层阴道镜医生诊断表现不佳是宫颈癌筛查体系中的难点和痛点。开展阴道镜培训是提高基层医生诊断水平的有效方式,但由于我国基层医生人数众多且操作经验较少,专家线下授课的培训模式进展较为缓慢。随着计算机技术的发展和临床大数据的积累,研发一款科学、权威、实用、富有趣味性的智能化培训软件有望提升阴道镜医生的诊断水平。本研究旨在介绍研发智能阴道镜培训软件的研究意义、研究内容和相关研究进展,并探讨其应用的优势及现实挑战。 Unsatisfactory performance of grassroots colposcopists impedes cervical cancer screening in China.The training courses are most effective for cultivating large number of qualified colposcopists at grassroots level,but there is lack of sufficient trainers for offline training.With the advances of computer technology,it is feasible to develop a practical intelligent software of training colposcopy,which is expected to improve diagnostic ability of colposcopists.This article introduces significance,content and progress of intelligent software for colposcopy training,and discusses its advantages and challenges.
作者 秦东旭 钱天翼 薛鹏 江宇 乔友林 QIN Dong-xu;QIAN Tian-yi;XUE Peng;JIANG Yu;QIAO You-lin(School of Population Medicine and Public Health,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;School of Medicine Tsinghua University,Beijing 100084,China;Tencent Healthcare Ca Ltd.,Shenzhen518057,China)
出处 《中国肿瘤》 CAS CSCD 北大核心 2021年第10期784-788,共5页 China Cancer
基金 中国医学科学院医学与健康科技创新工程项目(CIFMS2017-I2M-B&R-03)。
关键词 阴道镜 宫颈癌 筛查 智能化 培训软件 colposcope cervical cancer screening intelligent training software
  • 相关文献

参考文献8

二级参考文献67

  • 1刘继红,关明飞,钱德英,黄欣,黄鹤,李玉洁.中国和澳大利亚妇女子宫颈上皮内瘤变人乳头瘤病毒感染和相关危险因素的病例对照研究[J].中华流行病学杂志,2007,28(10):958-963. 被引量:11
  • 2Yang BH,Bray FI,Parkin DM,et al. Cervical cancer as a priority for prevention in different world regions:an evalu- ation using years of life lost [J]. Int J Cancer,2004,109 (3) : 418-424.
  • 3乔友林,张林琦.人乳头瘤病毒引起宫颈癌机理和人免疫缺陷病毒的发现-2008年诺贝尔生理学/医学奖评述[A].中国科学院2009科学发展报告[M].北京:中国科学院,2009.112-119.
  • 4Schiller JT,Castellsague X,Villa LL,et al. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results [J]. Vaccine,2008,26(suppl 10):K53-61.
  • 5Joura EA, Giuliano AR,lversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women[J]. N Engl J Med, 2015,372(8) : 711-723.
  • 6Kirby T. FDA approves new upgraded Gardasil 9 [J]. Lancet Oncol, 2015,16(2) : e56.
  • 7Agorastos T, Chatzigeorgiou K, Brotherton JM ,et al. Safety of human papillomavirus(HPV) vaccines:a review of the international experience so far [J]. Vaccine,2009,27(52): 7270-7281.
  • 8Allen JD,Coronado GD,Williams RS,et al. A systematic review of measures used in studies of human papillo- mavirus (HPV) vaccine acceptability[J]. Vaccine,2010,28 (24) :4027-4037.
  • 9Wigle J,Coast E,Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries(LMICs):heahh system experiences and prospects [J]. Vaccine,2013,3l(37) : 3811-3817.
  • 10Camp EA,Prehn AW,Shen J,et al. Factors associated with a lack of pap smear utilization in women exposed inutero to diethylstilbestrol[J]. J Womens Health (Larchmt), 2015,24(4) : 308-315.

共引文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部